Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.
gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries.Their primary focus is on providing better hazard identification assays for genotoxicity through the use of their patented human cell GADD45a reporter assays GreenScreen® HC and BlueScreen HC.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 15, 2021 | Series Unknown | £700K | 1 | Mercia Fund Managers | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mercia Fund Managers | Yes | Series Unknown |